Bhavnagri Veer
SEC CIK 1808980 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics, Inc. | GC | 556.0K | — | $488.4K | 12 | 2021-07-15 | 2023-03-14 |
Most active insiders at ALLO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chang David D | Pres, CEO, Dir | — | $289.5K |
| 2 | Roberts Zachary | EVP of R, D | — | $104.2K |
| 3 | Douglas Earl Martin | SVP, GC | — | $103.3K |
| 4 | Parker Geoffrey M. | CFO | — | $88.5K |
| 5 | Beneski Benjamin Machinas | SVP, Chief Technical Off | — | $51.7K |
| 6 | Yoshiyama Annie | SVP, Fin | — | $29.3K |
| 7 | Kazam Joshua A | Dir | — | — |
Bhavnagri Veer made no open-market trades at ALLO in the last 12 months.
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-16 | 2023-03-14 | ALLO | Allogene Therapeutics, Inc. | Bhavnagri Veer | GC | F - Tax | $5.67 | -23.6K | 556.0K | -4% | -$134.0K | |
| 2023-02-14 | 2023-02-13 | ALLO | Allogene Therapeutics, Inc. | Bhavnagri Veer | GC | S - Sale | $6.85 | -3,000 | 577.7K | -0.5% | -$20.6K | |
| 2023-01-18 | 2023-01-17 | ALLO | Allogene Therapeutics, Inc. | Bhavnagri Veer | GC | S - Sale | $7.04 | -3,000 | 580.7K | -0.5% | -$21.1K | |
| 2022-12-19 | 2022-12-15 | ALLO | Allogene Therapeutics, Inc. | Bhavnagri Veer | GC | S - Sale | $7.53 | -5,602 | 583.7K | -1.0% | -$42.2K | |
| D | 2022-03-25 | 2022-03-23 | ALLO | Allogene Therapeutics, Inc. | Bhavnagri Veer | GC | A - Grant | $0.00 | +175.4K | 589.3K | +42% | $0 |
| 2022-03-17 | 2022-03-15 | ALLO | Allogene Therapeutics, Inc. | Bhavnagri Veer | GC | S - Sale | $7.68 | -8,849 | 413.8K | -2% | -$68.0K | |
| D | 2021-09-17 | 2021-09-15 | ALLO | Allogene Therapeutics, Inc. | Bhavnagri Veer | GC | M - OptEx | $2.27 | +5,000 | 426.7K | +1% | +$11.3K |
| D | 2021-09-17 | 2021-09-15 | ALLO | Allogene Therapeutics, Inc. | Bhavnagri Veer | GC | S - Sale+OE | $24.77 | -5,000 | 421.7K | -1% | -$123.8K |
| D | 2021-08-17 | 2021-08-16 | ALLO | Allogene Therapeutics, Inc. | Bhavnagri Veer | GC | M - OptEx | $2.27 | +5,000 | 426.4K | +1% | +$11.3K |
| D | 2021-08-17 | 2021-08-16 | ALLO | Allogene Therapeutics, Inc. | Bhavnagri Veer | GC | S - Sale+OE | $21.00 | -5,000 | 421.4K | -1% | -$105.0K |
| D | 2021-07-16 | 2021-07-15 | ALLO | Allogene Therapeutics, Inc. | Bhavnagri Veer | GC | S - Sale+OE | $21.55 | -5,000 | 421.4K | -1% | -$107.8K |
| D | 2021-07-16 | 2021-07-15 | ALLO | Allogene Therapeutics, Inc. | Bhavnagri Veer | GC | M - OptEx | $2.27 | +5,000 | 426.4K | +1% | +$11.3K |
Purchase Sale Sale after option exercise All abbreviations